Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-002170
Filing Date
2025-06-17
Accepted
2025-06-17 17:21:52
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3758
2 baum_poa.htm EX-24 11622
  Complete submission text file 0000905148-25-002170.txt   16769
Mailing Address C/O MIRATI THERAPEUTICS INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121
Business Address
BAUM CHARLES M (Reporting) CIK: 0001579824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41551 | Film No.: 251054375

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)